Business Context and Reporting Period
Company: Chemed Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1997
Business Overview: Chemed operates through four primary segments: Roto-Rooter (plumbing and drain cleaning), National Sanitary Supply (paper products), Patient Care (home health care), and Omnia Group (paper products). The company reported 10,032,599 shares of common stock outstanding as of April 30, 1997.
Key Financial Metrics
| Metric (in thousands) | Q1 1997 | Q1 1996 |
|---|---|---|
| Total Sales and Service Revenues | $168,552 | $167,461 |
| Income from Operations | $6,455 | $7,011 |
| Net Income | $8,487 | $12,197 |
| Earnings Per Share (Basic) | $0.85 | $1.24 |
| Cash and Cash Equivalents (End of Period) | $17,797 | $41,965 |
| Net Cash Provided by Operating Activities | $6,599 | $12,116 |
| Total Debt (Current + Long-term) | $176,166 | N/A |
| Unused Lines of Credit | $50,300 | N/A |
Note: Total debt calculated as Current portion of long-term debt ($13,074) + Bank notes ($5,000) + Long-term debt ($158,092).
Material Changes vs. Prior Period
- Revenue: Total revenue increased slightly by 1% ($168.6M vs $167.5M). Growth was driven by Roto-Rooter (+8%) and Patient Care (+9%), offset by declines in National Sanitary Supply (-4%) and Omnia Group (-11%).
- Profitability: Operating income decreased 8% to $6.5M. Net income declined 30% to $8.5M, primarily due to a significant reduction in investment gains ($9.1M in 1997 vs $14.2M in 1996) and lower operating margins in the Omnia and National Sanitary Supply segments.
- Operating Margins: Consolidated operating margin fell from 5.2% to 4.5%. Roto-Rooter margin dipped to 8.6% (from 8.8%) due to additional goodwill amortization; Omnia margin dropped sharply to 4.2% (from 8.1%) due to lower selling prices.
- Liquidity: Cash and cash equivalents decreased from $42.0M to $17.8M, largely due to the sale of investments ($10.5M proceeds) and a decline in the market value of remaining investments ($6.8M).
- Debt Structure: In March 1997, the company borrowed $25 million in Senior Notes at 7.31% interest to reduce borrowings under its revolving credit agreement. Interest expense increased 43% to $2.8M.
Guidance, Outlook, and Risks
- Management Commentary: Management believes liquidity and capital sources are satisfactory for foreseeable needs. The company is aggressively training new home-health care aides to lower labor costs and improve margins in the Patient Care segment.
- Investment in Vitas Healthcare: Chemed holds a $27 million investment in Vitas Healthcare Corporation. Vitas is exploring long-term financing alternatives. Management believes the investment is fully recoverable with no permanent impairment, though this remains a contingency.
- Segment Risks:
- National Sanitary Supply: Margins impacted by deflationary pricing in the paper line and the loss of a large fast-food customer (though this loss no longer impacts year-over-year comparisons).
- Omnia Group: Margins pressured by lower paper-product selling prices, though market share was maintained.
- Patient Care: Lower gross margins due to reduced reimbursement rates, particularly in the New York market.
- Unusual Items: Net income includes significant non-operating investment gains. Excluding these gains, net income was $2.9M in Q1 1997 compared to $3.3M in Q1 1996.
Investor Verification Checklist
- Investment Gains: Verify the sustainability of earnings by analyzing net income excluding the $9.1M gain on sale of investments.
- Vitas Healthcare Exposure: Monitor the status of Vitas Healthcare's financing efforts and the potential for impairment on the $27M investment.
- Debt Servicing: Review the impact of the new $25M Senior Notes (7.31% interest) on future cash flows and interest coverage ratios.
- Margin Trends: Assess whether the margin compression in the Omnia and National Sanitary Supply segments is temporary or indicative of structural pricing issues.
- Goodwill Amortization: Confirm the impact of the additional goodwill amortization on the Roto-Rooter segment's reported margins.